← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksOLMARevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

OLMA logoOlema Pharmaceuticals, Inc. (OLMA) Revenue History

Annual and quarterly revenue from 2018 to 2025

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q4 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

OLMA Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

8 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

OLMA Revenue Analysis (2018–2025)

As of May 8, 2026, Olema Pharmaceuticals, Inc. (OLMA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.

Looking at the longer-term picture, OLMA's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including KYMR (-12.6% YoY). Compare OLMA vs KYMR →

OLMA Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
OLMA logoOLMACurrent$0---
KYMR logoKYMR$39M-12.6%+2.9%-891.3%
Best in groupLowest in group

OLMA Historical Revenue Data (2018–2025)

Showing 8 of 8 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$0-$0-$-178,698,000-
2024$0-$0-$-142,258,000-
2023$0-$0-$-104,961,000-
2022$0-$0-$-106,988,000-
2021$0-$0-$-71,491,000-
2020$0-$-11,000-$-21,528,000-
2019$0-$-9,033-$-4,323,000-
2018$0-$-8,244-$-2,079,000-

See OLMA's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is OLMA Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare OLMA vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

OLMA — Frequently Asked Questions

Quick answers to the most common questions about buying OLMA stock.

Is OLMA's revenue growth accelerating or slowing?

OLMA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is OLMA's long-term revenue growth rate?

Olema Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is OLMA's revenue distributed by segment?

OLMA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

OLMA Revenue Over Time (2018–2025)